États-Unis · Plateformes & données · Yahoo Finance

Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026

Publié par Yahoo Finance · États-Unis il y a 8 h

Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026 Halle (Saale) / Munich, Germany, October 30, 2026 - Vivoryon Therapeutics N.V. (Euronext…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026

À lire aussi

Kiniksa Pharmaceuticals International, plc $KNSA Shares Newly Bought by Fonville Wealth Management LLC

Panasonic Holdings Corporation GAAP EPS of ¥118.60, revenue of ¥4092.52B; updates FY2027 outlook

Will Midterm Elections Cause a Stock Market Crash? 4 Catalysts That Can Push the Trump Bull Market Over the Edge.

Unicaja reports third quarter profit above expectations

What gave this city its ‘best place to retire’ crown? You can actually afford to live there.

Scroll Corporation Delivers Strong Profit Growth and Boosts Dividends Amid Steady Sales

Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026

Partager

À lire aussi

Kiniksa Pharmaceuticals International, plc $KNSA Shares Newly Bought by Fonville Wealth Management LLC

Panasonic Holdings Corporation GAAP EPS of ¥118.60, revenue of ¥4092.52B; updates FY2027 outlook

Will Midterm Elections Cause a Stock Market Crash? 4 Catalysts That Can Push the Trump Bull Market Over the Edge.

Unicaja reports third quarter profit above expectations

What gave this city its ‘best place to retire’ crown? You can actually afford to live there.

Scroll Corporation Delivers Strong Profit Growth and Boosts Dividends Amid Steady Sales